Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND4L pseudogene 31 (MTND4LP31) is a nonfunctional genomic sequence related to the mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L gene (MT-ND4L). As a pseudogene, it does not code for any protein product and has no established biological or pathological role. There is no evidence supporting its use as a therapeutic target, biomarker, or clinical safety concern, and it is not associated with drug interactions or mechanisms of action. Pseudogenes such as MTND4LP31 are generally considered genomic relics resulting from the duplication or retrotransposition of functional gene sequences; they are neither expressed nor active in normal cellular physiology[6]. Summary: MT-ND4L pseudogene 31 (MTND4LP31) is a pseudogene and not a valid drug target, enzyme, receptor, or transporter. It is not implicated in disease, therapy, or any biological process, and there is something “incorrect” about considering it as a therapeutic target. The functional gene MT-ND4L has well-established mitochondrial roles, but pseudogenes do not share these properties[1][2][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L pseudogene 31 (MTND4LP31).